ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Cyclo Therapeutics Inc

Cyclo Therapeutics Inc (CYTH)

0.6642
-0.0558
(-7.75%)
終了 11月30日 6:00AM
0.6642
0.00
( 0.00% )
プレマーケット: 9:00PM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
0.6642
買値
0.6431
売値
0.7217
出来高
21
0.00 日の範囲 0.00
0.5946 52 週間の範囲 2.115
時価総額
前日終値
0.6642
始値
-
最終取引時間
22:00:04
財務取引量
-
VWAP
-
平均取引量 (3 か月)
30,782
発行済株式数
28,768,055
配当利回り
-
PER
-0.95
1 株当たり利益 (EPS)
-0.7
歳入
1.08M
純利益
-20.06M

Cyclo Therapeutics Inc について

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquapl... Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex. 詳細を表示

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
本社
Gainesville, Florida, USA
設立
-
Cyclo Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker CYTH. The last closing price for Cyclo Therapeutics was US$0.66. Over the last year, Cyclo Therapeutics shares have traded in a share price range of US$ 0.5946 to US$ 2.115.

Cyclo Therapeutics currently has 28,768,055 shares in issue. The market capitalisation of Cyclo Therapeutics is US$19.11 million. Cyclo Therapeutics has a price to earnings ratio (PE ratio) of -0.95.

CYTH 最新ニュース

Cyclo Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Strategic merger with Rafael Holdings to combine two companies and advance Trappsol® Cyclo™ for NPC1 patients expected to close Q4 2024 Company on track for topline data from the 48-week interim...

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results

NEWARK, N.J., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL), today reported its financial results for the fourth quarter and the full fiscal year ended July 31, 2024...

Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer

TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies, today announced the...

Cyclo Therapeutics Presents Encouraging Preliminary Safety Data from Ongoing Pivotal Phase 3 Study and Substudy for the Treatment of Niemann-Pick Disease Type C1 (NPC1)

Two posters presented at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2024 Pivotal TransportNPC™ study is the most comprehensive ongoing controlled pivotal...

Kuehn Law Encourages CYTH, ARCH, CEIX, and VGR Investors to Contact Law Firm

Kuehn Law Encourages CYTH, ARCH, CEIX, and VGR Investors to Contact Law Firm PR Newswire NEW YORK, Aug. 26, 2024 NEW YORK, Aug. 26, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation...

Rafael Holdings and Cyclo Therapeutics Enter Into a Definitive Merger Agreement

Cyclo Therapeutics’ TransportNPC™ Phase 3 clinical trial for Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is fully enrolled and results...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.0138-2.035398230090.6780.720.6292140.67989617CS
4-0.0478-6.713483146070.7120.770.6228600.69643472CS
12-0.0258-3.739130434780.690.820.5946307820.71246345CS
26-0.6158-48.1093751.281.40.5946516610.97665031CS
52-0.8458-56.01324503311.512.1150.5946724441.3620454CS
156-4.3158-86.66265060244.985.24990.5946731281.80365627CS
260-3.6858-84.73103448284.3517.750.59462009716.18950343CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
SNTISenti Biosciences Inc
US$ 5.67
(162.50%)
12.42M
PPBTPurple Biotech Ltd
US$ 5.59
(66.62%)
5.51M
UPBUpstream Bio Inc
US$ 34.77
(58.98%)
40
JCSEJE Cleantech Holdings Limited
US$ 1.86
(56.30%)
6.39M
SGBXSafe and Green Holdings Corporation
US$ 0.737
(50.41%)
25.91M
LGHLWLion Group Holding Ltd
US$ 0.0061
(-31.46%)
530
CWBCCommunity West Bancshares New
US$ 17.01
(-22.40%)
8
TTGTTech Target Inc
US$ 25.01
(-22.11%)
5
BOTJBank of the James Financial Group Inc
US$ 12.01
(-22.06%)
1
MDCXMedicus Pharma Ltd
US$ 2.10
(-21.64%)
295
SGBXSafe and Green Holdings Corporation
US$ 0.737
(50.41%)
25.91M
RGTIRigetti Computing Inc
US$ 3.4499
(13.11%)
18.75M
PRZOParaZero Technologies Ltd
US$ 1.60
(29.03%)
12.46M
SNTISenti Biosciences Inc
US$ 5.67
(162.50%)
12.42M
REVBRevelation Biosciences Inc
US$ 0.8598
(11.81%)
8.24M

CYTH Discussion

投稿を表示